Telix Pharmaceuticals Limited (ASX: TLX; Nasdaq: TLX, Telix, the Company) and Grand Pharmaceutical Group Limited (00512.HK, Grand Pharma) today announce that a first patient has been dosed in the ...
CABINET (randomized, double-blinded phase III study of CABozantinib versus placebo in patients with advanced ... In the US, Cabometyx tablets are approved as monotherapy for the treatment of patients ...